University of Virginia Cancer Center ( Site 0012) — Charlottesville, Virginia

University of Virginia Cancer Center ( Site 0012) is a clinical research site located in Charlottesville, Virginia, United States 22908.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Virginia Cancer Center ( Site 0012) has participated in 1 clinical trials.

Therapeutic areas: Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma.

Sponsors: VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Virginia Cancer Center ( Site 0012)?

University of Virginia Cancer Center ( Site 0012) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Virginia Cancer Center ( Site 0012) conducted?

University of Virginia Cancer Center ( Site 0012) has 1 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma.

Is University of Virginia Cancer Center ( Site 0012) accredited by Crixeo Health?

University of Virginia Cancer Center ( Site 0012) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Virginia Cancer Center ( Site 0012)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.